HL7.TERMINOLOGY\MedicationGeneralizationRoleType

This page is part of the HL7 Terminology (v2.1.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions

ValueSet: MedicationGeneralizationRoleType

Summary

Defining URL:

http://terminology.hl7.org/ValueSet/v3-MedicationGeneralizationRoleType

Version:

2.0.0

Name:

MedicationGeneralizationRoleType

Status:

Active as of 2014-03-26

Definition:

Identifies the specific hierarchical relationship between the playing and scoping medications.

Examples: Generic, Generic Formulation, Therapeutic Class, etc.

OID:

2.16.840.1.113883.1.11.19720 (for OID based terminology systems)

Source Resource:

XML / JSON / Turtle

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Include codes from http://terminology.hl7.org/CodeSystem/v3-RoleCode where concept is-a _MedicationGeneralizationRoleType

Expansion

This value set contains 6 concepts

Expansion based on RoleCode v2.1.0 (CodeSystem)

All codes from system http://terminology.hl7.org/CodeSystem/v3-RoleCode

Lvl	Code	Display	Definition
0	_MedicationGeneralizationRoleType	MedicationGeneralizationRoleType	Identifies the specific hierarchical relationship between the playing and scoping medications. Examples: Generic, Generic Formulation, Therapeutic Class, etc.
1	DC	therapeutic class	Description:A categorization of medicinal products by their therapeutic properties and/or main therapeutic use.
1	GD	generic drug	Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients independent of strength, and form. The scoping entity identifies a unique combination of medicine ingredients; sometimes referred to as "ingredient set".
2	GDF	generic drug form	Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients and dose form, independent of strength of the ingredients. The scoping entity identifies a unique combination of medicine ingredients in a specific dose form.
2	GDS	generic drug strength	Relates a manufactured drug product to the non-proprietary (generic) representation of is ingredients with their strength. The scoping entity identifies a unique combination of medicine ingredients with their strength.
2	GDSF	generic drug strength form	Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.
1	MGDSF	manufactured drug strength form	Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

Source

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code

History

Date

Action

Custodian

Author

Comment

2020-05-06

revise